EverSource Wealth Advisors’s Alnylam Pharmaceuticals ALNY Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $143K | Sell |
437
-18
| -4% | -$5.87K | 0.01% | 1021 |
|
|
2025
Q1 | $123K | Buy |
455
+39
| +9% | +$10.5K | 0.01% | 838 |
|
|
2024
Q4 | $97.9K | Buy |
416
+93
| +29% | +$21.9K | 0.01% | 905 |
|
|
2024
Q3 | $88.8K | Buy |
323
+25
| +8% | +$6.88K | 0.01% | 838 |
|
|
2024
Q2 | $70.8K | Buy |
298
+24
| +9% | +$5.7K | ﹤0.01% | 936 |
|
|
2024
Q1 | $39.4K | Buy |
274
+60
| +28% | +$8.64K | ﹤0.01% | 1074 |
|
|
2023
Q4 | $41K | Buy |
214
+184
| +613% | +$35.2K | ﹤0.01% | 976 |
|
|
2023
Q3 | $5.31K | Sell |
30
-73
| -71% | -$12.9K | ﹤0.01% | 1682 |
|
|
2023
Q2 | $19.6K | Buy |
103
+82
| +390% | +$15.6K | ﹤0.01% | 1163 |
|
|
2023
Q1 | $4.21K | Sell |
21
-23
| -52% | -$4.61K | ﹤0.01% | 1704 |
|
|
2022
Q4 | $10.5K | Sell |
44
-3
| -6% | -$713 | ﹤0.01% | 1320 |
|
|
2022
Q3 | $10K | Buy |
+47
| New | +$10K | ﹤0.01% | 1120 |
|
|
2022
Q1 | – | Sell |
-7
| Closed | -$1K | – | 1697 |
|
|
2021
Q4 | $1K | Buy |
+7
| New | +$1K | ﹤0.01% | 1673 |
|